Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page
- Check7 days agoChange Detected- The page's revision label updated from v3.5.4 to v3.5.5, indicating a new build/version of the page. - The previous revision label has been replaced by the new one, reflecting an incremental update to the site.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now lists Revision: v3.5.4 instead of v3.5.3, signaling a minor site update. No study content or critical functionality appears to be affected.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s footer indicates an update to the ClinicalTrials.gov interface/version (revision v3.5.3 instead of v3.5.2). This reflects a version change of the site rather than an update to the trial details.SummaryDifference0.1%

- Check57 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the site metadata.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.